Robert L. Whitener

Robert L. Whitener

Auto-generated profile, based on publicly available information

Robert L. Whitener

Stanford University School of Medicine 1 Department of Developmental Biology Stanford, CA 94305 , USA

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 March 2020 in Development
Verified
Journal Article
Open access
PDF file
SKSeokho Kim
Seokho Kim
RWRobert L. Whitener
Robert L. Whitener
HPHeshan Peiris
Heshan Peiris
XGXueying Gu
Xueying Gu
CCCharles A. Chang
Charles A. Chang
SKSeung K. Kim
Seung K. Kim
Reliance on rodents for understanding pancreatic genetics, development and islet function could limit progress in developing interventions for human diseases such as diabetes mellitus. Similarities of pancreas morphology and function suggest that porcine and human pancreas developmental biology may have useful homologies. However, little is known about pig pancreas development. To fill this knowledge gap, we investigated fetal and neonatal pig pancreas at multiple, crucial developmental stages using modern experimental approaches. Purification of islet β-, α- and δ-cells followed by transcriptome analysis (RNA-seq) and immunohistology identified cell- and stage-specific regulation, and revealed that pig and human islet cells share characteristic features that are not observed in mice. Morphometric analysis also revealed endocrine cell allocation and architectural similarities between pig and human islets. Our analysis unveiled scores of signaling pathways linked to native islet β-cell functional maturation, including evidence of fetal α-cell GLP-1 production and signaling to β-cells. Thus, the findings and resources detailed here show how pig pancreatic islet studies complement other systems for understanding the developmental programs that generate functional islet cells, and that are relevant to human pancreatic diseases.

1 November 2014 in Veterinary Immunology and Immunopathology
Verified
Journal Article
Closed access
BABianca L. Artiaga
Bianca L. Artiaga
RWRobert L. Whitener
Robert L. Whitener
CSCharles R. Staples
Charles R. Staples
JDJohn Driver
John Driver

1 May 2019 in Frontiers in Immunology
Verified
Journal Article
Open access
CLChao Liu
Chao Liu
RWRobert L. Whitener
Robert L. Whitener
ALAndrea Lin
Andrea Lin
YXYuan Xu
Yuan Xu
JCJing Chen
Jing Chen
CMClayton E. Mathews
Clayton E. Mathews
Aims: Reactive oxygen species (ROS) are critical in driving the onset of type 1 diabetes (T1D). Ablation of ROS derived from phagocytic NADPH oxidase 2 (NOX2) is significantly protective against autoimmune diabetes in non-obese diabetic (NOD) mice. However, the mechanisms of NOX2-derived ROS in T1D pathogenesis need to be elucidated. Here, we have examined the role of NOX2 in dendritic cells (DC). Results: DC deficient in NOX2 exhibited reduced capacity to activate autoreactive CD8+ T cells. Instead of altering dendritic cell surface co-stimulatory molecule expression or promoting pro-inflammatory cytokine production, ROS promote CD8+ T cell activation by facilitating autoantigen cross-presentation. When provided with exogenous protein antigen, NOX2 deficient NOD DCs showed strong phagosome acidification and rapid antigen degradation, which lead to an absence of protein translocation into the cytoplasm and deficient antigenic peptide loading on MHC Class I molecules. Innovation: This study demonstrates that NOX2 is required for activation and effector function of CD8+ T cells by acting both intrinsically within the T cell as well as within professional antigen presenting cells. Conclusion: ROS scavengers could potentially represent an important component for therapies aiming to disrupt autoantigen presentation and activation of CD8+ T cells in individuals at-risk for developing T1D.

15 December 2017 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
RWRobert L. Whitener
Robert L. Whitener
LKLisa Gallo Knight
Lisa Gallo Knight
JLJianwei Li
Jianwei Li
SKSarah Knapp
Sarah Knapp
SZShuyao Zhang
Shuyao Zhang
CMClayton E Mathews
Clayton E Mathews
Type 1 diabetes (T1D) has a strong genetic component. The insulin dependent diabetes (Idd)22 locus was identified in crosses of T1D-susceptible NOD mice with the strongly T1D-resistant ALR strain. The NODcALR-(D8Mit293-D8Mit137)/Mx (NOD-Idd22) recombinant congenic mouse strain was generated in which NOD mice carry the full Idd22 confidence interval. NOD-Idd22 mice exhibit almost complete protection from spontaneous T1D and a significant reduction in insulitis. Our goal was to unravel the mode of Idd22-based protection using in vivo and in vitro models. We determined that Idd22 did not impact immune cell diabetogenicity or β cell resistance to cytotoxicity in vitro. However, NOD-Idd22 mice were highly protected against adoptive transfer of T1D. Transferred CTLs trafficked to the pancreatic lymph node and proliferated to the same extent in NOD and NOD-Idd22 mice, yet the accumulation of pathogenic CTLs in the islets was significantly reduced in NOD-Idd22 mice, correlating with disease resistance. Pancreatic endothelial cells from NOD-Idd22 animals expressed lower levels of adhesion molecules, even in response to inflammatory stimuli. Lower adhesion molecule expression resulted in weaker adherence of T cells to NOD-Idd22 endothelium compared with NOD-derived endothelium. Taken together, these results provide evidence that Idd22 regulates the ability of β cell–autoreactive T cells to traffic into the pancreatic islets and may represent a new target for pharmaceutical intervention to potentially prevent T1D.